| CTRI Number |
CTRI/2024/05/067080 [Registered on: 09/05/2024] Trial Registered Prospectively |
| Last Modified On: |
08/05/2024 |
| Post Graduate Thesis |
Yes |
| Type of Trial |
Observational |
|
Type of Study
|
Follow Up Study |
| Study Design |
Other |
|
Public Title of Study
|
Assessment of impact of late-onset growth retardation on brain development of fetuses in comparison with normally growing fetuses using fetal MRI. |
|
Scientific Title of Study
|
Assessment of variability in cortical development in late-onset IUGR fetuses using foetal MRI. |
| Trial Acronym |
NIL |
|
Secondary IDs if Any
|
| Secondary ID |
Identifier |
| NIL |
NIL |
|
|
Details of Principal Investigator or overall Trial Coordinator (multi-center study)
|
| Name |
Dr Akshat Rastogi |
| Designation |
Junior Resident |
| Affiliation |
Kasturba Medical College, Manipal |
| Address |
Department of Radiodiagnosis and Imaging, Kasturba Medical college, Manipal Udupi KARNATAKA 576104 India
Udupi KARNATAKA 576104 India |
| Phone |
9919955226 |
| Fax |
|
| Email |
akshat.rastogi98@gmail.com |
|
Details of Contact Person Scientific Query
|
| Name |
Dr Prakashini K |
| Designation |
Professor |
| Affiliation |
Kasturba Medical College Manipal |
| Address |
Department of Radiodiagnosis and Imaging, Kasturba Medical college, Manipal Udupi KARNATAKA 576104 India
Udupi KARNATAKA 576104 India |
| Phone |
9845053325 |
| Fax |
|
| Email |
prakashini.k@manipal.edu |
|
Details of Contact Person Public Query
|
| Name |
Dr Prakashini K |
| Designation |
Professor |
| Affiliation |
Kasturba Medical College Manipal |
| Address |
Department of Radiodiagnosis and Imaging, Kasturba Medical college, Manipal Udupi KARNATAKA 576104 India
KARNATAKA 576104 India |
| Phone |
9845053325 |
| Fax |
|
| Email |
prakashini.k@manipal.edu |
|
|
Source of Monetary or Material Support
|
| KASTURBA MEDICAL COLLEGE MANIPAL |
|
|
Primary Sponsor
|
| Name |
Kasturba Medical College Manipal |
| Address |
Kasturba Medical College, Manipal, Udupi, Karnataka- 576104 |
| Type of Sponsor |
Private medical college |
|
|
Details of Secondary Sponsor
|
|
|
Countries of Recruitment
|
India |
|
Sites of Study
|
| No of Sites = 1 |
| Name of Principal
Investigator |
Name of Site |
Site Address |
Phone/Fax/Email |
| Dr Akshat Rastogi |
Kasturba Hospital, Kasturba Medical College, Manipal |
Room no. 3, Main MRI,
Department of
Radiodiagnosis and
Imaging, Kasturba
medical college, MAHE,
Manipal Udupi
KARNATAKA- 576104 Udupi KARNATAKA |
9919955226
akshat.rastogi98@gmail.com |
|
|
Details of Ethics Committee
|
| No of Ethics Committees= 1 |
| Name of Committee |
Approval Status |
| Kasturba Medical College and Kasturba hospital institutional ethics committee 2 |
Approved |
|
|
Regulatory Clearance Status from DCGI
|
|
|
Health Condition / Problems Studied
|
| Health Type |
Condition |
| Patients |
(1) ICD-10 Condition: O365||Maternal care for known or suspected poor fetal growth, |
|
|
Intervention / Comparator Agent
|
| Type |
Name |
Details |
| Intervention |
NIL |
NIL |
|
|
Inclusion Criteria
|
| Age From |
18.00 Year(s) |
| Age To |
45.00 Year(s) |
| Gender |
Female |
| Details |
1.Late onset IUGR Fetuses(greater than 32 weeks of gestational age) as per antenatal scan criteria
2. Appropriate for gestational age fetuses( greater than 32 weeks of gestational age) as per antenatal scan criteria |
|
| ExclusionCriteria |
| Details |
1. Motion artifacts during MRI acquisition
2. Incidentally diagnosed brain pathologies
3. Multiple Pregnancies
4. Chronic Maternal disease
5. Perinatal Infections |
|
|
Method of Generating Random Sequence
|
Not Applicable |
|
Method of Concealment
|
Not Applicable |
|
Blinding/Masking
|
Not Applicable |
|
Primary Outcome
|
| Outcome |
TimePoints |
1. Does intra-uterine growth restriction affect cortical development? Yes/ No
2. Fetal MRI cortical development parameter(s) that showed significance and their recommended cutoffs
|
Greater than 32 weeks of gestational age
|
|
|
Secondary Outcome
|
| Outcome |
TimePoints |
Perinatal outcome is affected in IUGR Foetuses:
Yes/No |
At birth of the fetus |
|
|
Target Sample Size
|
Total Sample Size="56" Sample Size from India="56"
Final Enrollment numbers achieved (Total)= "Applicable only for Completed/Terminated trials"
Final Enrollment numbers achieved (India)="Applicable only for Completed/Terminated trials" |
|
Phase of Trial
|
N/A |
|
Date of First Enrollment (India)
|
19/05/2024 |
| Date of Study Completion (India) |
Applicable only for Completed/Terminated trials |
| Date of First Enrollment (Global) |
Date Missing |
| Date of Study Completion (Global) |
Applicable only for Completed/Terminated trials |
|
Estimated Duration of Trial
|
Years="2" Months="0" Days="0" |
|
Recruitment Status of Trial (Global)
|
Not Applicable |
| Recruitment Status of Trial (India) |
Not Yet Recruiting |
|
Publication Details
|
N/A |
|
Individual Participant Data (IPD) Sharing Statement
|
Will individual participant data (IPD) be shared publicly (including data dictionaries)?
Response - NO
|
|
Brief Summary
|
The study will enroll all clinically referred participants based on specific inclusion and exclusion
criteria during the designated period. Demographic details in the form of age, hospital number, and
period of gestation as per last USG would be recorded. Written informed consent will be taken from
the patients and PCPNDT F form would be filled and signed by the radiologist and the patient. Imaging process will be performed after 4 hours of fasting and without sedation, while the patient
will be positioned in supine. Brain MRI will be taken at 3 different orthogonal planes. If motion
artifact degradation is detected, the sequence will be repeated until a satisfactory image is
obtained. Following parameters will be measured and recorded: Fissure depths- Biparietal diameter, Bilateral insular depths, bilateral cingulate fissure depths Cortical thickness- Bilateral insula, temporal lobe, frontal lobe, occipital lobe, corpus callosum
length
Area- Areas: Whole brain area, Cerebellum, Corpus callosum The patient will be followed up till birth and following perinatal outcomes would be assessed at birth
Gestational age at birth(weeks), birthweight (in grams), Neonatal acidosis, APGAR score at 5 mins,
NICU stay length(days), Other perinatal complications.
Radiological findings would be analyzed and statistically significant parameters would be put forth
as neuro-imaging biomarkers for assessing cortical development in-utero.
If any incidental pathology/defect is discovered in the foetus, findings will be communicated to the
referring obstetrician to decide the further course of action. |